LEUVEN, BELGIUM - March 2, 2021. Materialise, a global leader in medical 3D printing and planning solutions, has added new technology to support left atrium appendage occlusion (LAAO) procedures to its Mimics Enlight cardiovascular planning software suite. Making it possible to leverage the Mimics Enlight 3D planning technology for this procedure to mitigate risk and improve efficiency.
Leuven, Belgium, – December 2, 2020. Materialise NV (Nasdaq:MTLS), a global leader in 3D printing solutions, has released SurgiCase software, an online case management system (CMS) for personalized medical devices. The SurgiCase software, will give medical device companies and clinicians a single location to exchange data, communicate about procedural planning and check the status of their cases. This reduces the administrative overhead and ultimately helps these companies to help more patients with a personalized device at a lower cost.
RSNA Annual Meeting – (Nov. 30, 2020). Materialise NV (Nasdaq: MTLS), a global leader in medical 3D printing software and services, introduced its new Mimics VR Viewer today at the RSNA Annual Meeting, bringing virtual reality (VR) capabilities to its popular 3D modeling platform.
Leuven, Belgium - November 10, 2020. Materialise NV (Nasdaq: MTLS), a leading company in 3D technology solutions in the industrial and medical markets, announces it obtained the CE Marking Certification for most of its personalized orthopaedic and cranio-maxillofacial (CMF) solutions. This includes 3D-printed anatomical models and patient-matched surgical guides and implants. Materialise is a pioneer and world leader of personalized solutions, helping patients and surgeons in six continents with the production of over 350,000 personalized devices. The company became one of the first to acquire this kind of certification for a large, personalized, 3D-printed medical device portfolio. This certification will make the technology more accessible for surgeons.
Leuven, Belgium / Rio Claro, Brazil – August 1, 2019. Materialise, a global leader in 3D printing solutions, today announced a strategic investment in Engimplan, a Brazil-based manufacturer of orthopedic and cranio-maxillofacial (CMF) implants and instruments. The combination of Materialise’s expertise in 3D printed medical solutions with Engimplan’s innovative product portfolio will help to accelerate the introduction of 3D printed, personalized implants and instruments in the Brazilian market.